Loading company…
OrigiMed develops techniques to detect abnormal genetic information for cancer and provides medical counseling services for patients.
Established in 2016 and based in Shanghai, China, OrigiMed operates and develops detection techniques for abnormal genetic information related to cancer. The company also provides medical counseling services for patients. It is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in